SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-230110
Filing Date
2023-09-07
Accepted
2023-09-07 07:37:12
Documents
71
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d477278d6k.htm   iXBRL 6-K 170386
2 EX-99.1 d477278dex991.htm   iXBRL EX-99.1 914879
3 EX-99.2 d477278dex992.htm EX-99.2 113731
4 EX-99.3 d477278dex993.htm EX-99.3 77115
  Complete submission text file 0001193125-23-230110.txt   5970252

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mreo-20230630.xsd EX-101.SCH 69287
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mreo-20230630_cal.xml EX-101.CAL 43476
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20230630_def.xml EX-101.DEF 264451
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20230630_lab.xml EX-101.LAB 394616
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20230630_pre.xml EX-101.PRE 352451
65 EXTRACTED XBRL INSTANCE DOCUMENT d477278d6k_htm.xml XML 1085953
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 231240980
SIC: 2834 Pharmaceutical Preparations